| GAPLINC | gastric cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29785127 | 2018 |
| GAPLINC | osteosarcoma | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 30177521 | 2018 |
| GAPLINC | perihilar cholangiocarcinoma | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30128015 | 2018 |
| GAPLINC | non small cell lung cancer | qPCR, Western blot, Other | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 31447565 | 2019 |
| GAPLINC | hepatocellular carcinoma | qPCR, Western blot, RNAi, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✘ | 31415284 | 2019 |
| GAPLINC | glioblastoma multiforme | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30657584 | 2019 |
| GAPLINC | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 30522114 | 2018 |
| GAPLINC | bladder cancer | qPCR, Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 29725414 | 2018 |
| GAPLINC | colorectal cancer | microarray, qPCR, Western blot, RNA pull-down assay etc. | H | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 27259250 | 2016 |
| GAPLINC | gastric cancer | microarray, ISH etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 25277524 | 2014 |
| GAPLINC | colorectal cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown etc. | H | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 29427222 | 2017 |
| GAPLINC | gastric cancer | qPCR, RNAi, Western blot, RIP, ChIP, Luciferase reporter assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 27729869 | 2016 |
| GAPLINC | gastric cancer | qPCR, Western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 29785127 | 2018 |